Endocannabinoid Response in Acute Ischemic Stroke
- 1 May 2021
- journal article
- letter
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 52 (5), E131-E132
- https://doi.org/10.1161/strokeaha.121.034131
Abstract
Supplemental Digital Content is available in the text.This publication has 5 references indexed in Scilit:
- Detrimental effects of 2-arachidonoylglycerol on whole blood platelet aggregation and on cerebral blood flow after a focal ischemic insult in ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2018
- Possible Anandamide and Palmitoylethanolamide involvement in human strokeLipids in Health and Disease, 2010
- The endocannabinoid 2-AG protects the blood–brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokinesNeurobiology of Disease, 2006
- Release of Fatty Acid Amides in a Patient With Hemispheric StrokeStroke, 2002
- An endogenous cannabinoid (2-AG) is neuroprotective after brain injuryNature, 2001